Global market valuation was derived through revenue mapping, production capacity analysis, and procedure volume modeling. The methodology included:
Identification of 50+ key manufacturers across Malaysia, Thailand, China, Indonesia, North America, and Europe, representing nitrile, natural rubber latex, vinyl (PVC), and neoprene/polychloroprene glove production;
Product mapping across examination gloves, surgical gloves (sterile and non-sterile), and chemotherapy-rated gloves (ASTM D6978 compliant);
Analysis of reported and modeled annual revenues specific to disposable glove portfolios, incorporating capacity utilization rates (billions of pieces per annum) and average selling prices (ASP) segmented by material thickness and sterility status;
Coverage of manufacturers representing 75-80% of global market share in 2024, including Top Glove Corporation, Hartalega Holdings, Ansell Ltd., Kimberly-Clark Corporation, and Supermax Corporation;
Extrapolation using bottom-up approach (procedure volume × ASP by country, incorporating surgical volumes, examination visits, and industrial safety mandates) and top-down validation (manufacturer revenue reconciliation, Malaysian Rubber Council export value verification, and UN Comtrade import data triangulation) to derive segment-specific valuations for medical vs. non-medical applications;
Raw material price tracking (butadiene and acrylonitrile indices for nitrile; latex concentrate RSS3 prices for natural rubber) to model cost-pass-through mechanisms and margin elasticity across different glove chemistries.